| Stage | ZBRA | % of rev | THC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $5.6B | 100.00% | THC ×3.62 |
| Gross profit | $825M | 52.99% | $3.5B | 61.41% | THC +8.4pp |
| Operating income | $321M | 20.62% | $1.8B | 31.08% | THC +10.5pp |
| Pre-tax income | $285M | 18.30% | $1.6B | 28.04% | THC +9.7pp |
| Net income | $233M | 14.96% | $1.2B | 21.65% | THC +6.7pp |
| Stage | ZBRA | THC | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $5.6B100.00% | THC ×3.62 |
| Gross profit | 52.99%$825M | 61.41%$3.5B | THC +8.4pp |
| Operating income | 20.62%$321M | 31.08%$1.8B | THC +10.5pp |
| Pre-tax income | 18.30%$285M | 28.04%$1.6B | THC +9.7pp |
| Net income |
| 14.96%$233M |
| 21.65%$1.2B |
| THC +6.7pp |
No shared counterparties.